AnaptysBio, Inc.
USD68.10
+2.13 (+3.23%)
CEO
Daniel Faga
IPO Date
2017-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$66.30
Prev. Close
$65.97
Day Low
$65.59
Day High
$68.42
52W Low
$11.40
52W High
$72.36
Market Cap
$2.94B
Volume
0.09M
| -1.7 |
| 31 Dec 2023 | FY | -671.0% | -953.7% | -185.7% | -36.2% | 0.20 | 10.87 | -2.3 |
| 31 Dec 2022 | FY | -763.2% | -1251.3% | -49.1% | -21.1% | 0.07 | 17.16 | -4.5 |
| 31 Dec 2021 | FY | -55.9% | -91.5% | -16.2% | -9.0% | 0.06 | 34.40 | -11.0 |
| 31 Dec 2020 | FY | -6.7% | -26.6% | -5.0% | -4.8% | 0.00 | 20.01 | -19.6 |
| 31 Dec 2019 | FY | -1141.7% | -1216.7% | -24.0% | -22.4% | 0.01 | 12.79 | -3.0 |
| 31 Dec 2018 | FY | -1023.9% | -1233.1% | -12.7% | -12.1% | 0.02 | 19.89 | -17.0 |
| 31 Dec 2017 | FY | -194.4% | -300.7% | -9.8% | -9.1% | 0.05 | 17.93 | -44.2 |
| 31 Dec 2016 | FY | 7.6% | -25.5% | -10.8% | -6.8% | 0.35 | 10.20 | -7.0 |
| 4.5 |
| 30 Sept 2025 | Q3 | 58.8% | 19.8% | -51.4% | 4.3% | -11.78 | 8.68 | 9.8 |
| 30 Jun 2025 | Q2 | -69.9% | -173.5% | 86.4% | -11.5% | -0.34 | 8.22 | -2.8 |
| 31 Mar 2025 | Q1 | -48.3% | -141.6% | -115.6% | -9.3% | 0.46 | 8.25 | -2.4 |
| 31 Dec 2024 | Q4 | 1.2% | -50.5% | -30.7% | -4.5% | 0.23 | 9.51 | -3.1 |
| 30 Sept 2024 | Q3 | -40.6% | -109.4% | -38.9% | -6.7% | 0.20 | 10.23 | -4.9 |
| 30 Jun 2024 | Q2 | -282.8% | -425.3% | -472.3% | -10.9% | 1.72 | 9.09 | -2.4 |
| 31 Mar 2024 | Q1 | -416.0% | -612.0% | -92.0% | -10.8% | 6.86 | 11.53 | -2.2 |
| 31 Dec 2023 | Q4 | -272.3% | -468.8% | -47.9% | -9.3% | 0.20 | 10.87 | -2.2 |